id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-N-0899-0807,FDA,FDA-2011-N-0899,United States Senate to FDA - Letter,Other,Letter(s),2013-05-03T04:00:00Z,2013,5,2013-05-03T04:00:00Z,,2013-05-03T20:21:41Z,,0,0,09000064812b66f3
FDA-2011-N-0899-0806,FDA,FDA-2011-N-0899,Congress of the United States House of Representatives to FDA - Letter,Other,Letter(s),2013-05-03T04:00:00Z,2013,5,2013-05-03T04:00:00Z,,2013-05-03T20:20:22Z,,0,0,09000064812b66f1
FDA-2011-N-0899-0685,FDA,FDA-2011-N-0899,Draft Environmental Assessment and Preliminary Finding of No Significant Impact Concerning a Genetically Engineered Atlantic Salmon; Extension of Comment Period,Notice,Extension of Comment Period,2013-02-15T05:00:00Z,2013,2,2013-02-14T05:00:00Z,2013-04-27T03:59:59Z,2015-12-23T22:00:45Z,2013-03445,0,0,09000064811fb853
FDA-2011-N-0899-0626,FDA,FDA-2011-N-0899,"United States Senate, Senator Mark Begich, et al., Letter Dated January 11, 2013, to the Commissioner, FDA - Request for Extension of the Comment Due Date",Other,Request for Extension,2013-02-07T05:00:00Z,2013,2,2013-02-07T05:00:00Z,,2013-02-08T00:08:33Z,,0,0,09000064811ecbe5